Effects of Nerve Blocks on Pain After Caesarean Section and Postpartum Depression

Last updated: September 3, 2024
Sponsor: Kahramanmaras Sutcu Imam University
Overall Status: Active - Enrolling

Phase

N/A

Condition

Acute Pain

Pain

Chronic Pain

Treatment

Nerve block

Clinical Study ID

NCT06221280
2023/10-02
  • Ages > 18
  • Female
  • Accepts Healthy Volunteers

Study Summary

At the end of your cesarean section surgery, which is started by applying medication to the spinal cavity from your waist, pain medication will be applied between the relevant muscle and its covering from your lower abdomen or back with the help of ultrasonography and a special block needle. Then, a patient-controlled pain device with a serum containing painkillers will be connected to your vascular access, and its use and purpose will be explained to you. You will be asked about your pain condition and the severity score of your pain, if any, at certain hourly intervals. At the end of 24 hours, a pain device will be removed, your satisfaction will be questioned and your complaints, if any, will be recorded. Immediately before surgery and 4-6 days after your surgery. An evaluation survey consisting of 10 questions will be asked to you within a 5-minute period during the weeks, at a time when you are free, and your answers will be recorded.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Having a good mental status,

  2. Those aged ≥18 years,

  3. Term pregnant (gestational age ≥ 36 weeks),

  4. American Society of Anesthesiologists class II-III,

  5. Patients who underwent cesarean section with spinal anesthesia will be included.

Exclusion

Exclusion Criteria:

  1. Having labor at term or obstetric emergency,

  2. Having a twin pregnancy,

  3. Having a diagnosed psychiatric disorder/using psychiatric medication,

  4. Those who are allergic to local anesthetics and/or drugs used in the study,

  5. The patient-controlled anesthesia device is out of use for any reason within thefirst 24 hours postoperatively,

  6. Having peripheral neuropathy or neuromuscular disease,

  7. Patients using anticoagulant drugs that will prevent regional anesthesia will beexcluded from the study.

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: Nerve block
Phase:
Study Start date:
November 01, 2023
Estimated Completion Date:
October 01, 2024

Connect with a study center

  • KahramanmarasSIU

    Kahramanmaraş, 46100
    Turkey

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.